In 2023, 49 new drugs (excluding vaccines and gene therapies) received their first approval in the United States, the European Union, and Japan. Among them, 40 drugs have specific mechanism of action targets. Among them, there are 12 novel targets that have not been previously approved for drug modulation. See Table 1
Table 1 Drugs approved in 2023 with novel mechanism of action targets (source: nature).
药 Drug | 种类 Categories | 作用靶点机制 Mechanism of action target | 靶点 Target | 治疗疾病 Cure disease | 批准 Approval |
Fezolinetant | 小分子抑制剂 Small-molecule inhibitor | Read More
Related News
Artificial Intelligence in Precision Cancer Care: Unlocking the Future of Personalized Oncology
Muhammad Farhan Khalid August 22, 2025 Hengrui's Application for New Class 1.1 Drug Hetrombopag Ethanolamine Tablets was Accepted by CDE
PharmaSources/Dopine June 19, 2020 Breakthrough Therapy for Type 2 Immune Indications: the Ten Billion dollars drug Dupilumab will be marketed in China
PharmaSources/1℃ June 19, 2020 You may like
Fezolinetant
Fezolinetant Intermedaite CAS:922178-61-8
Fezolinetant
API Fezolinetant
Fezolinetant Intermediate CAS:1375066-73-1
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation! Subscribe
Note: You can unsubscribe from the alerts at any time. Most popular
The Rise of Biosimilars: Regulatory Pathways and Market Outlook
Nurah Ekhlaque
Sep 19, 2025
Basic Concepts and Latest Trends in Radiation Biology: Emerging Insights and Future Directions
Sadia Ajmal
Sep 18, 2025
Convert secures €13.6m grant to develop targeted chemo for oxygen-deprived tumours
pharmafile
Mar 12, 2018
New Products MORE
中文站-新建产品-en
High Temperature Banana Oil Magnetic Coupling Pump Set for Diesel Fuel
test-Product Name1
![]()
Cell Culture Flask
![]()
Aseptic Transfer Cap
![]()
SUS Aseptic Welder
|










(All Rights Reserved)